2-苄基己二酸 | 22935-14-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 中文名称: 2-苄基己二酸
• 英文名称: 2-Benzyladipinsaeure
• 英文别名: 2-Benzylhexanedioic acid
• CAS: 22935-14-4
• 化学式: C₁₃H₁₆O₄
• 分子量: 236.268
• InChiKey: CZICSOZHJCBPNW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-苄基己二酸 在 氯化亚砜 作用下， 生成 Monobenzyl adipoyl chloride
  参考文献：
  名称：

  Aromatische Spirane, 16. Mitt.: Darstellung von monound dianellierten 2,2?-Spirobiindan-1,1?-dionen

  摘要：

  DOI：

  10.1007/bf00810848
• 作为产物：
  描述：

  3-亚苄基-2-氧代-环戊基羧酸乙酯 在 palladium on activated charcoal sodium hydroxide 、 氢气 作用下， 以 乙酸乙酯 为溶剂， 生成 2-苄基己二酸
  参考文献：
  名称：

  Schroth,W.; Treibs,W., Justus Liebigs Annalen der Chemie, 1961, vol. 639, p. 214 - 228

  摘要：

  DOI：

文献信息

• [EN] SUBSTITUTED ADIPIC ACID AMIDES AND USES THEREOF<br/>[FR] AMIDES DE L'ACIDE ADIPIQUE SUBSTITUÉS ET LEURS UTILISATIONS
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2012125622A1

  公开（公告）日：2012-09-20

  The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A is a five to eight membered monocyclic or a nine to twelve membered bicyclic heterocyclic ring, as further defined herein; Y is S, CH2, or CH; Z is CH or N; R7 and R9 are hydrogen or (C1-C6)alkyl; R2 is (C1 C6)alkoxy, OH, CN, (C1-C6)alkyl, halogen, or CF3; r and s are 0, 1, or 2; and R1 and R3 are as further defined herein. These compounds are agonists, partial agonists and/or modulators of the NPY4 receptor and may be used for the treatment and prophylaxis of obesity, food intake, and other diseases and conditions modulated by the NPY4 receptor.

  本发明提供了式（I）的化合物或其药学上可接受的盐，其中A是一个五至八元的单环或一个九至十二元的双环杂环环，如本文所进一步定义；Y是S、CH2或CH；Z是CH或N；R7和R9是氢或（C1-C6）烷基；R2是（C1-C6）烷氧基、羟基、氰基、（C1-C6）烷基、卤素或三氟甲基；r和s为0、1或2；R1和R3如本文所进一步定义。这些化合物是NPY4受体的激动剂、部分激动剂和/或调节剂，可用于治疗和预防肥胖、食物摄入和其他由NPY4受体调节的疾病和症状。
• Bridged zirconocene compounds, process for their preparation and their use as catalyst components in the polymeriaztion of olefins
  申请人：Montell Technology Company B.V.

  公开号：US20010014751A1

  公开（公告）日：2001-08-16

  Zirconocene compounds with two indenyl ligands linked in the 2 position by means of a two-carbon-atoms divalent bridging group can be suitably used as components of catalysts for the polymerization of olefins. Particularly it is possible to prepare, with high yields, ethylene (co)polymers having low molecular weights and narrow molecular weight distributions, without the need of using considerable amounts of molecular weight regulators, such as hydrogen.

  二茂锆配合物具有两个茚基配体，通过双碳原子二价桥接基在2位连接，可作为催化剂的组分，适用于烯烃的聚合。特别是可以高产率地制备分子量较低、分子量分布较窄的乙烯（共）聚合物，而无需使用大量分子量调节剂，如氢气。
• Bridged zirconocene compounds, process for their preparation and their use as catalyst components in the polymerization of olefins
  申请人：Montell Technology Company B.V.

  公开号：US20020039962A1

  公开（公告）日：2002-04-04

  Zirconocene compounds with two indenyl ligands linked in the 2 position by means of a two-carbon-atoms divalent bridging group can be suitably used as components of catalysts for the polymerization of olefins. Particularly it is possible to prepare, with high yields, ethylene (co)polymers having low molecular weights and narrow molecular weight distributions, without the need of using considerable amounts of molecular weight regulators, such as hydrogen.

  具有两个茚基配体的二茂钨化合物，通过一个双价桥连基团在2位置连接，可以作为催化剂的组分，适用于烯烃的聚合。特别是可以高产地制备分子量低、分子量分布窄的乙烯（共）聚合物，而无需使用大量的分子量调节剂，如氢气。
• SUBSTITUTED ADIPIC ACID AMIDES AND USES THEREOF
  申请人：Sun Chongqing

  公开号：US20130345123A1

  公开（公告）日：2013-12-26

  The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A is a five to eight membered monocyclic or a nine to twelve membered bicyclic heterocyclic ring, as further defined herein; Y is S, CH 2 , or CH; Z is CH or N; R 7 and R 9 are hydrogen or (C 1 -C 6 )alkyl; R 2 is (C 1 -C 6 )alkoxy, OH, CN, (C 1 -C 6 )alkyl, halogen, or CF 3 ; r and s are 0, 1, or 2; and R 1 and R 3 are as further defined herein. These compounds are agonists, partial agonists and/or modulators of the NPY4 receptor and may be used for the treatment and prophylaxis of obesity, food intake, and other diseases and conditions modulated by the NPY4 receptor.

  本发明提供了式（I）的化合物或其药学上可接受的盐，其中A是进一步定义的五至八元杂环或九至十二元双环杂环；Y是S，CH2或CH；Z是CH或N；R7和R9是氢或（C1-C6）烷基；R2是（C1-C6）烷氧基，羟基，氰基，（C1-C6）烷基，卤素或CF3；r和s为0、1或2；而R1和R3的定义进一步如下。这些化合物是NPY4受体的激动剂、部分激动剂和/或调节剂，可用于治疗和预防肥胖、食物摄入和其他受NPY4受体调节的疾病和状况。
• Catalyst-controlled site-selective methylene C–H lactonization of dicarboxylic acids
  作者：Hau Sun Sam Chan、Ji-Min Yang、Jin-Quan Yu

  DOI：10.1126/science.abq3048

  日期：2022.6.24

  and γ-methylene carbon-hydrogen (C-H) bonds of free carboxylic acids is a long-standing challenge. Here we show that, with a pair of palladium catalysts assembled with quinoline-pyridone ligands of different chelate ring sizes, it is possible to perform highly site-selective monolactonization reactions with a wide range of dicarboxylic acids, generating structurally diverse and synthetically useful γ-

  游离羧酸的β-和γ-亚甲基碳氢（CH）键的催化剂控制的位点选择性活化是一个长期存在的挑战。在这里，我们表明，通过一对由不同螯合环尺寸的喹啉-吡啶酮配体组装的钯催化剂，可以与多种二羧酸进行高度位点选择性的单内酯化反应，产生结构多样且合成上有用的γ-和δ-内酯通过位点选择性β-或γ-亚甲基CH活化。剩余的羧基可作为进一步合成应用的多功能关键，如从丰富的二羧酸中全合成两种天然产物 myrotheciumone A 和pedicellosine 所证明的那样。